PetMed Express, Inc. (PETS)

Market Cap	84.16M
Revenue (ttm)	247.01M
Net Income (ttm)	357,000
Shares Out	20.63M
EPS (ttm)	0.02
PE Ratio	239.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	293,688
Open	4.130
Previous Close	4.190
Day's Range	3.965 - 4.180
52-Week Range	2.900 - 6.850
Beta	0.79
Analysts	Sell
Price Target	3.50 (-14.22%)
Earnings Date	Feb 10, 2025

About PETS

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthri...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 287
• Stock Exchange: NASDAQ
• Ticker Symbol: PETS
• Website: https://www.1800petmeds.com

Analyst Forecast

According to 2 analysts, the average rating for PETS stock is "Sell." The 12-month stock price forecast is $3.5, which is a decrease of -14.22% from the latest price.

Price Target

$3.5

(-14.22% downside)

Analyst Consensus: Sell